Cero Therapeutics Holdings CERO
OTC CERO
$0.00 0.00 (-19.61%)
As of: Oct 23, 2026 · 12:24 PM EDT

Cero Therapeutics Holdings (CERO) Net Debt Issuances and Repayments (2023 - 2026)

Updated

Analysis

Cero Therapeutics Holdings (CERO) Net Debt Issuances and Repayments (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Debt Issuance (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 11.58 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn -4.36 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn -2.00 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn -5.00 Mn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn 2.17 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn -2.46 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -17.00 Mn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 64.00 Mn
10 Cero Therapeutics Holdings 210,875.10 -5.27 Mn - 2.16 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.16 Mn
Mar 31, 2026 1.50 Mn
Jun 30, 2025 124,131.00
Dec 31, 2024 -102,274.00
Sep 30, 2024 -150,895.90
Mar 31, 2024 388,337.00
Dec 31, 2023 160,001.00
Sep 30, 2023 219,999.00
API Access

Cero Therapeutics Holdings Net Debt Issuances and Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-debt-issuances-and-repayments&ticker=CERO&period=max&api_key=YOUR_API_KEY